Does Anthem (Elevance Health) Cover Spironolactone for Acne?

Anthem's Coverage Policy for Spironolactone

Anthem (Elevance Health) classifies generic spironolactone as a covered medication across its commercial PPO and HMO product lines. Coverage extends to the drug's FDA-approved indications, which include heart failure with reduced ejection fraction, edema associated with hepatic cirrhosis, primary hyperaldosteronism, and essential hypertension. The acne indication, however, is not FDA-approved, and that distinction drives additional utilization management steps.

Because hormonal acne falls under off-label prescribing, Anthem requires prior authorization before dispensing. The PA process asks your prescriber to document that the patient is female, has a diagnosis of acne vulgaris (ICD-10 L70.0), and has tried and failed at least one first-line topical therapy. A 2017 systematic review by Layton et al. in the British Journal of Dermatology confirmed that spironolactone reduces acne lesion counts by 50% to 100% in women with hormonal acne, providing the clinical evidence base that supports off-label coverage requests. Anthem medical directors review these requests against published evidence and the American Academy of Dermatology (AAD) guidelines, which recognize spironolactone as a second-line systemic therapy for adult female acne.

Your prescriber can submit the PA electronically through Anthem's provider portal or by fax. Standard review takes 5 to 10 business days. Urgent requests receive a 72-hour turnaround.

What Formulary Tier Is Spironolactone on Anthem Plans?

Generic spironolactone (25 mg, 50 mg, and 100 mg tablets) sits on Tier 1 or Tier 2 of most Anthem commercial formularies. Tier 1 preferred generics carry copays of $0 to $10, while Tier 2 non-preferred generics range from $10 to $25 per fill at a 30-day supply.

Anthem updates its formulary quarterly. The specific tier can shift between plan years and varies by employer group. Your most reliable check is the Anthem online formulary lookup tool, where you enter your member ID and search for "spironolactone" to see your plan's current tier and any quantity limits.

Quantity limits on spironolactone for acne are uncommon on Anthem plans. Most policies allow up to 60 tablets per 30-day fill (consistent with the standard 100 mg twice-daily ceiling dose), though the typical acne dose ranges from 50 mg to 150 mg daily. A retrospective cohort study published in the Journal of the American Academy of Dermatology (JAAD) found that 74% of women prescribed spironolactone for acne used doses between 50 mg and 100 mg daily, and that higher doses did not produce statistically significant additional benefit in lesion clearance.

The cash price for generic spironolactone without insurance averages $4 to $15 per month at major chain pharmacies, making it one of the least expensive acne treatments available. This matters. If your copay exceeds the cash price, ask your pharmacist to run the prescription outside insurance.

Step Therapy Requirements on Anthem

Anthem mandates step therapy for spironolactone when prescribed for acne. This means your prescriber must document that you have tried and had an inadequate response to (or experienced intolerance of) at least one topical acne medication before Anthem will authorize spironolactone.

Qualifying step-therapy agents typically include:

• Topical retinoids (tretinoin, adapalene, tazarotene)
• Benzoyl peroxide (2.5%, 5%, or 10%)
• Topical antibiotics (clindamycin, erythromycin)
• Combination products (adapalene/benzoyl peroxide, clindamycin/benzoyl peroxide)

Anthem generally accepts a minimum 8- to 12-week trial of a topical agent as adequate step therapy. The AAD's 2024 guidelines on acne management recommend topical retinoids as first-line therapy for most acne types, with oral spironolactone reserved for adult women whose acne is hormonally driven and has not responded to topical therapy alone.

If you have already completed step therapy with a previous insurer or during a prior plan year, ask your prescriber to include that documentation in the PA submission. Anthem will typically accept historical step-therapy completion if the prescriber provides dates and agents used. Losing months of progress because of an insurance change is avoidable with proper documentation.

How to Get Prior Authorization Approved

The PA approval rate for spironolactone on Anthem plans is moderate. Denials happen most often when the submission lacks clinical documentation. Here is a step-by-step approach that increases your odds of first-pass approval.

What your prescriber should include in the PA request:

1. Diagnosis of acne vulgaris (L70.0) with notation that the pattern is hormonal (jawline, chin, lower face distribution)
2. Patient sex: female (spironolactone carries a pregnancy category C label; Anthem will not authorize it for male patients for acne)
3. List of topical agents tried, with dates and duration of each trial
4. Clinical outcome of each topical trial (inadequate response, adverse reaction, or contraindication)
5. Requested dose and duration (most PA approvals are granted for 6 to 12 months)
6. Reference to published clinical evidence, such as the Layton et al. systematic review or the Cochrane review of hormonal therapies for acne

A 2020 analysis in JAMA Dermatology found that prior authorization requirements for dermatologic medications delayed treatment initiation by an average of 7 days and that 21% of initial PA requests were denied across all insurers studied. Having complete documentation at the time of the first submission is the single best predictor of approval.

Your prescriber's office should receive a determination within 5 to 10 business days for standard requests. If the PA is approved, coverage typically extends for 6 to 12 months before renewal is required.

How to Appeal an Anthem Denial of Spironolactone

Anthem operates a two-tier internal appeal system. If your initial PA request is denied, you have 180 days from the denial date to file a first-level appeal.

First-level appeal: Your prescriber submits a letter of medical necessity along with supporting clinical evidence. Include specific outcome data. For example, a randomized controlled trial by Sato et al. (J Dermatol, 2006) demonstrated 85% improvement in acne severity scores among women treated with spironolactone 200 mg daily over 20 weeks. Anchor your appeal in published evidence, not anecdotal claims. Anthem's medical director reviews first-level appeals, and decisions are typically issued within 30 calendar days.

Second-level appeal: If the first-level appeal is denied, you can request a second review. This review is conducted by a physician who was not involved in the original denial.

External independent review: After exhausting internal appeals, you can request an external review through your state's independent review organization (IRO). The IRO decision is binding on Anthem. According to the Endocrine Society's Clinical Practice Guidelines, spironolactone is a recognized treatment for androgen-mediated skin conditions in women, which provides additional support for external review arguments.

Keep copies of all denial letters, appeal submissions, and correspondence. A peer-to-peer review (a phone call between your prescriber and Anthem's medical director) can often resolve denials faster than the written appeal pathway. Ask your prescriber's office to request a peer-to-peer as soon as a denial is issued.

Spironolactone Cost With and Without Anthem Coverage

The financial picture for spironolactone is unusually favorable compared to most acne medications.

| Scenario | Monthly cost | |---|---| | Anthem Tier 1 generic copay | $0 to $10 | | Anthem Tier 2 generic copay | $10 to $25 | | Cash price without insurance (GoodRx, Mark Cuban Cost Plus) | $4 to $15 | | Manufacturer list price (branded Aldactone) | ~$80 | | Anthem high-deductible plan (pre-deductible) | $4 to $20 |

For patients on high-deductible health plans (HDHPs) who have not yet met their deductible, the cash price may be lower than the insurer-negotiated rate. Pharmacists can process the prescription at cash price upon request, and this does not affect your insurance benefits.

Manufacturer copay cards are not available for generic spironolactone because no single manufacturer holds a patent. However, programs like GoodRx, RxSaver, and the Mark Cuban Cost Plus Drug Company offer generic spironolactone at $4 to $8 per month, which undercuts most insurance copays. The FDA Orange Book lists over 15 approved generic manufacturers for spironolactone tablets, which sustains this low pricing.

Clinical Context: Why Spironolactone for Acne

Spironolactone is a potassium-sparing diuretic that also blocks androgen receptors. In women with hormonal acne, androgens drive excess sebum production in pilosebaceous units, and spironolactone reduces this androgen activity at the receptor level.

The evidence base is strong. A 2019 Cochrane review of spironolactone for acne and hirsutism concluded that spironolactone significantly reduces acne lesion counts in women, though the review authors noted that more large-scale randomized trials were needed. The SAFA trial (Spironolactone for Adult Female Acne), a randomized controlled trial of 410 women published in the BMJ in 2023, found that spironolactone 50 mg (titrated to 100 mg if needed) reduced acne severity by 1.0 point on the Investigator's Global Assessment scale compared to 0.6 points for placebo at 24 weeks (P<0.001).

Standard prescribing starts at 25 to 50 mg daily and titrates to 100 to 150 mg daily over 4 to 8 weeks. Full clinical effect takes 3 to 6 months. Baseline potassium and renal function labs are recommended at initiation and after dose changes, per the Endocrine Society's guidelines on androgen excess.

Spironolactone is contraindicated in pregnancy (teratogenic risk: feminization of a male fetus) and is not prescribed for acne in males due to anti-androgenic side effects including gynecomastia. Anthem's PA criteria reflect these restrictions.

Anthem Medicaid and Medicare Plans

Coverage differs on Anthem Medicaid managed care and Medicare Advantage plans. On Medicaid, spironolactone is typically covered without PA for its FDA-approved indications, but off-label acne use may require additional documentation depending on state Medicaid formulary rules. On Medicare Advantage (Part D), spironolactone is covered under the pharmacy benefit, but the acne indication is more frequently denied because Medicare coverage standards emphasize FDA-approved uses.

If you are on an Anthem Medicare Advantage plan and need spironolactone for acne, your prescriber may need to document comorbid conditions (e.g., heart failure, hypertension, hyperaldosteronism) as the primary indication to secure coverage. This is a common and legitimate prescribing pattern when a patient has both acne and a cardiovascular indication.

According to the CDC's National Ambulatory Medical Care Survey, acne accounts for approximately 5.1 million physician office visits annually in the United States, and about 33% of female acne patients over age 25 receive a hormonal therapy such as spironolactone or combined oral contraceptives.